Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909]
Marie-Louis Wronski , Franziska Plessow , Liya Kerem , Elisa Asanza , Michelle L. O'Donoghue , Fatima C. Stanford , Miriam A. Bredella , Martin Torriani , Alexander A. Soukas , Arvin Kheterpal , Kamryn T. Eddy , Tara M. Holmes , Thilo Deckersbach , Mark Vangel , Laura M. Holsen , Elizabeth A. Lawson
{"title":"Corrigendum to “A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods” [Contemporary Clinical Trials 122 (2022) 1-11/106909]","authors":"Marie-Louis Wronski , Franziska Plessow , Liya Kerem , Elisa Asanza , Michelle L. O'Donoghue , Fatima C. Stanford , Miriam A. Bredella , Martin Torriani , Alexander A. Soukas , Arvin Kheterpal , Kamryn T. Eddy , Tara M. Holmes , Thilo Deckersbach , Mark Vangel , Laura M. Holsen , Elizabeth A. Lawson","doi":"10.1016/j.cct.2024.107511","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551714424000946/pdfft?md5=457492376d7505e8d19a05fd3b71e605&pid=1-s2.0-S1551714424000946-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714424000946","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.